Quick Answer
ABEONA THERAPEUTICS INC. reported Research And Development Expense of $26.81 million for the year ending 2025.
- ABEONA THERAPEUTICS INC. showed a decrease of -22.0% in Research And Development Expense from 2024 to 2025.
- This data is from ABEONA THERAPEUTICS INC.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), ABEONA THERAPEUTICS INC.'s Research And Development Expense has grown by 700.6%.
- Historical annual values: Fiscal year 2025: $26.81 million | Fiscal year 2024: $34.36 million | Fiscal year 2023: $31.09 million | Fiscal year 2022: $28.97 million | Fiscal year 2021: $38.73 million | Fiscal year 2020: $30.14 million | Fiscal year 2019: $48.57 million | Fiscal year 2018: $38.70 million | Fiscal year 2017: $16.99 million | Fiscal year 2016: $10.66 million | Fiscal year 2015: $4.72 million | Fiscal year 2014: $333.0 thousand | Fiscal year 2013: $884.0 thousand | Fiscal year 2012: $2.01 million | Fiscal year 2011: $3.58 million | Fiscal year 2010: $3.35 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: